Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

China · Delayed Price · Currency is CNY

12.58

-0.05 (-0.40%)

Sep 30, 2026, 3:04 PM CST

SHE:300534 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	737.9	886.96	1,043	1,080	799.68	287.81
Revenue Growth	-24.96%	-14.92%	-3.48%	35.06%	177.85%	12.91%
Gross Profit	489.07	603.55	751.13	693.26	458.06	92.33
Operating Income	62.46	87.47	96.02	81.82	56.31	-9.31
Net Income	34.55	43.95	24.48	61.65	38.79	-9.11
Earnings Per Share	0.11	0.14	0.08	0.20	0.13	-0.03
EPS Growth	34.67%	79.55%	-60.28%	58.87%	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
China	874.83	1,034	1,071	789.4	275.55
Foreign	12.13	8.4	8.63	10.28	12.26
Total	886.96	1,043	1,080	799.68	287.81

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	169.22	241.33	310.02	288.95	369.24	99.12
Total Debt	123.62	132.51	114.68	144.54	-	-
Net Cash (Debt)	45.6	108.82	195.34	144.4	369.24	99.12
Net Cash Growth	-44.10%	-44.29%	35.27%	-60.89%	272.52%	105.97%
Net Cash Per Share	0.15	0.36	0.64	0.48	1.22	0.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	41.75	-6.54	214.92	96.53	267.44	51.13
Capital Expenditures	-30.26	-43.36	-77.69	-126.36	-25.41	-0.41
Free Cash Flow	11.49	-49.9	137.23	-29.83	242.03	50.72
Free Cash Flow Growth	-	-	-	-	377.18%	103.30%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	66.28%	68.05%	72.05%	64.19%	57.28%	32.08%
Operating Margin	8.46%	9.86%	9.21%	7.58%	7.04%	-3.24%
Pretax Margin	10.49%	9.15%	9.76%	8.98%	8.27%	-1.65%
Profit Margin	4.68%	4.96%	2.35%	5.71%	4.85%	-3.16%
FCF Margin	1.56%	-5.63%	13.16%	-2.76%	30.27%	17.62%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.040	0.040	0.040	0.020
Dividend Per Share Growth	0%	0%	100.00%	-
Dividend Yield	0.32%	0.42%	0.46%	0.21%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	110.44	65.43	107.82	48.57	69.37	-
P/FCF Ratio	332.05	-	19.23	-	11.12	88.04
PS Ratio	5.17	3.24	2.53	2.77	3.37	15.51